OTHER GROUP COMPANIES
market

Marksans Pharma stocks skyrocket 6% after UK MHRA approves Loperamide 2mg Hard Capsules

The company will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility located in Goa, India.

December 10, 2021 12:00 IST | India Infoline News Service
Marksans Pharma
Marksans Pharma has announced that UK MHRA has granted Market Authorisation to the Company's wholly-owned subsidiary Relonchem Limited for Loperamide 2mg Hard Capsules.

The company will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility located in Goa, India.

At around 11.57 am, Marksans was trading at Rs63.25 per piece up by 5.7% on Sensex.

The stock was near the intraday high of Rs64.40 per piece on the same index.

The stock had opened at Rs62.50 per piece. 

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity